- Home
- YORW vs FLGT Comparison
YORW vs FLGT Comparison
Compare YORW & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YORW | FLGT |
|---|---|---|
| Founded | 1816 | 2011 |
| Country | United States | United States |
| Employees | 104 | 1315 |
| Industry | Water Supply | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.0M | 511.2M |
| IPO Year | 1994 | 2016 |
Fundamental Metrics
Financial Performance| Metric | YORW | FLGT |
|---|---|---|
| Price | $30.20 | $15.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | 126.0K | ★ 885.2K |
| Earning Date | 03-03-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $77,488,000.00 | $18,730,000.00 |
| Revenue This Year | $11.78 | $10.09 |
| Revenue Next Year | $4.95 | $12.18 |
| P/E Ratio | $21.92 | ★ N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $29.68 | $13.46 |
| 52 Week High | $36.48 | $31.04 |
Technical Indicators
Market Signals| Indicator | YORW | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 35.52 | 36.57 |
| Support Level | $30.02 | $13.46 |
| Resistance Level | $32.98 | $22.48 |
| Average True Range (ATR) | 0.68 | 0.58 |
| MACD | -0.08 | 0.50 |
| Stochastic Oscillator | 20.72 | 53.39 |
Price Performance
Historical ComparisonAbout YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.